Updates from The Motley Fool

Latest updates on Myriad Genetics from Fool.com.


Stock Performance

MYGN vs. S&P 500 | 2 Year Performance
MYGN 1-Day Stock Chart
MYGN 5-Day Stock Chart
MYGN 1-Month Stock Chart
MYGN 3-Month Stock Chart
MYGN 6-Month Stock Chart
MYGN 1-Year Stock Chart
MYGN 2-Year Stock Chart
MYGN 5-Year Stock Chart
View Interactive MYGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Myriad Genetics.
Current Price: $36.00
Prev Close: $37.15
Open: $36.89
Bid: $35.00
Ask: $39.09
Day's Range: $35.63 - $37.06
52wk Range: $30.30 - $46.24
Volume: 603,482
Avg Vol 806,360
Market Cap: $2.51B
P/E (ttm): 27.93
EPS (ttm): $1.33
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Myriad Genetics.
CAPS Rating 3 out of 5
 
522 Outperform
92 Underperform
CAPS All Stars
 
117 Outperform
15 Underperform

How do you think Myriad Genetics will perform against the market?



You pick for Myriad Genetics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark C. Capone, CEO

100% Approve

Based on 10 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Myriad Genetics.

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

  • Exchange: NASDAQ
  • Sector: Services
  • Industry: Diversified Services